Everest Medicines (HKG:1952) said a substantial shareholder, CBC Group, purchased 712,000 shares in the company for about HK$19.2 million between June 16 and June 17, according to a Thursday Hong Kong bourse filing.
The shares were acquired at an average price of HK$26.99 each.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.